MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    The comparison of cognitive function between normal and abnormal FDG-PET in non-demented Parkinson’s disease

    SJ. Kim, EJ. Chung (Busan, Republic of Korea)

    Objective: The aim is to compare the cognitive function between normal and abnormal FDG-PET in non-demented Parkinson’s disease (PD). Background: PD with mild cognitive impairment…
  • 2019 International Congress

    Impact of Cognitive Profile on Impulse Control Disorders Presence and Severity in Parkinson’s Disease

    A. Martini, L. Weis, E. Fiorenzato, R. Schifano, V. Cianci, A. Antonini, R. Biundo (Newcastle-­under­-Lyme, United Kingdom)

    Objective: To investigate whether Parkinson’s disease (PD) cognitive states and phenotypes are associated with changes in prevalence and severity of Impulse control disorder (ICD). Background:…
  • 2019 International Congress

    Specific SLC6A3 variant shows association with better memory in PD patients longitudinally

    M. Ramezani, K. Martens, JS. Provost, I. Kathol, Z. Javer, J. Cheetham, E. Yoon, M. Kibreab, T. Hammer, ST. Lang, T. Alrazi, A. Robichaud, JR. Sarna, D. Martino, G. Pfeffer, O. Monchi (Calgary, AB, Canada)

    Objective: To study the effect of SLC6A3VNTR on PD patients’ cognition longitudinally. Background: Solute carrier family 6 neurotransmitter transporter dopamine member 3gene (SLC6A3) has two common…
  • 2019 International Congress

    Role of Alzheimer’s Disease Genetic Risk Variant rs9331896 in Cognitive Decline in Parkinson’s Disease

    T. Tropea, L. Baratta, K. Maddy, M. Guo, J. Rick, V. van Deerlin, J. Trojanowski, D. Weintraub, A. Chen-Plotkin (Philadelphia, PA, USA)

    Objective: To investigate whether susceptibility loci for Alzheimer's disease (AD) are associated with rates of longitudinal cognitive decline in Parkinson’s disease (PD). Background: Parkinson’s disease…
  • 2019 International Congress

    Dysbiosis of Gut Microbiota in a selected population of Italian Parkinson’s Disease patients

    R. Cerroni, D. Pietrucci, M. Conti, V. Unida, A. Farcomeni, M. Pierantozzi, NB. Mercuri, S. Biocca, A. Desideri, A. Stefani (Rome, Italy)

    Objective: Our main objective was to investigate dysbiosis of gut microbiota in a selected population of Parkinson’s disease (PD) patients from center-south of Italy, examining…
  • 2019 International Congress

    Synchronization Study of Regional Local Field Potential in Rat with Dopamine Receptor Stimulation

    SH. Lin, SY. Chen, YY. Chen (Hualien, Taiwan)

    Objective: The aim of this study attempts to explore the non-linear interaction with cross-frequency coupling in rats during the stimulation of dopamine receptors. Background: Investigating…
  • 2019 International Congress

    Motor compensation in Parkinson’s disease: a multimodal neuroimaging study

    N. Villain, N. Pyatigorskaya, S. Lehericy, R. Vallabregue, S. Fernandez-Vidal, MO. Habert, G. Mangone, JC. Corvol, M. Vidailhet, D. Grabli (Paris, France)

    Objective: To study motor compensation mechanisms in Parkinson's disease. Background: Whereas akinesia in Parkinson's disease (PD) is linked to dopaminergic neurons death and striatal dopamine depletion,…
  • 2019 International Congress

    Frequency and pattern of movement disorders in a Neurologic clinic in North Central Nigeria: a 3- year review

    E. Iwuozo, R. Obiako (Makurdi, Nigeria)

    Objective: This study evaluated the frequency and pattern of movement disorders in a neurology clinic in a tertiary hospital in North Central Nigeria over a…
  • 2019 International Congress

    A Registry for Parkinson’s Disease in Utah

    P. Moretti, A. Nakashima, M. Zorn, S. Woltz, L. Farese, L. Cannon-Albright, S. Pulst (Salt Lake City, UT, USA)

    Objective: To report the progress made in establishing the Utah Parkinson Disease Registry (UPDR.org). Background: Precise epidemiological information about Parkinson’s disease (PD) and related conditions…
  • 2019 International Congress

    LATE ONSET OF PARKINSON’S DISEASE

    I. Smolentseva, N. Amosova, A. Kuzmina (Moscow, Russian Federation)

    Objective: To study the clinical manifestations of Parkinson's disease with a late onset. Background: Parkinson's disease (PD) is common in the elderly, the average age…
  • « Previous Page
  • 1
  • …
  • 133
  • 134
  • 135
  • 136
  • 137
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley